3) This question doesn't really make sense. The Purpose of table 1 is to break down the values under the reporting groups. ScO doesn't need to be represented in table 1 as it is represented in table 2 individually. I mean you could put it in table 1 but you would just be doubling up on information and it would be unnecessary. It's the same with the molecules after ScO in table 2 as well
Ann: Clarification on Makuutu DFS, page-9
Add IXR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.69M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $65.34K | 6.269M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3990304 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 2494116 | 5 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IXR (ASX) Chart |